Business description
Repligen Corporation is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.
Management board & Supervisory board
| CEO |
| Tony J. Hunt |
| Management board |
| Jason K. Garland, Olivier Loeillot, James R. Bylund, Christine Gebski, Ralf Kuriyel |
| Supervisory board |
| Karen A. Dawes, Nicolas M. Barthelemy, Tony J. Hunt, Konstantin Konstantinov, Martin D. Madaus, Carrie Eglinton Manner, Rohin Mhatre, Glenn P. Muir, Maggie A. Pax |
Company data
| Name: |
Repligen Corp. |
| Address: |
41 Seyon street, building 1, suite 100,Waltham, Massachusetts, 02453 |
| Phone: |
+1-781-250-0111 |
| Fax: |
+1-781-250-0115 |
| E-mail: |
customerserviceUS@repligen.com
|
| Internet: |
www.repligen.com/ |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
12/31 |
| Free Float: |
93.43% |
| IPO date: |
- |
